explore -WSS

explore

author：comprehensive 2025-10-01 22:48:29 - browse：3

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

knowledge

leisure time

WSS

Flagship, Pfizer team up in deal worth up to $7 billion

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Search warrant issued in 1996 disappearance of Kristin Smart

Why you get paid to donate plasma but not blood

Adele warns fans about throwing things at performers onstage

Lack of darker skin in textbooks, journals harms patients of color

Wikipedia

explore

hotspot

Supreme Court strikes down use of affirmative action

Biden administration sends mixed signals on US soldier who crossed into North Korea

Apple is now the first public company to be valued at $3 trillion

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Moonlake's readout produced a cash windfall. Risks remain

Why you get paid to donate plasma but not blood

Activists slam private health insurers over coverage restrictions

House passes resolution saying Israel isn't a 'racist or apartheid state'

Medicare proposal to cover medical devices draws a mixed reaction

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

focus

Lack of darker skin in textbooks, journals harms patients of color

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Biden administration sends mixed signals on US soldier who crossed into North Korea

A strong 6.5

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Johnson & Johnson sues to stop Medicare negotiation

knowledge

knowledge

leisure time

focus